Results 211 to 220 of about 24,019 (239)

A gene for neurofibromatosis 2

Nature, 1993
Kenneth W. Kinzler, Bert Vogelstein
openaire   +1 more source

Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma.

The American journal of pathology, 1995
There is evidence from cytogenetic and loss of heterozygosity studies for the involvement of a tumor suppressor gene on chromosome 22 in the formation of meningiomas. Recently, the NF2 gene, which causes neurofibromatosis type 2 and which is located in the affected region on chromosome 22, has been identified.
R, Wellenreuther, J A, Kraus, D, Lenartz, A G, Menon, J, Schramm, D N, Louis, V, Ramesh, J F, Gusella, O D, Wiestler, A, von Deimling   +9 more
openaire   +1 more source

Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.

Cancer research, 1994
Ependymomas and astrocytomas commonly have allelic losses of chromosome 22q, which suggests the presence of a glioma tumor suppressor gene on 22q. A candidate tumor suppressor gene on 22q is the neurofibromatosis 2 (NF2) gene since NF2 patients have an increased susceptibility to ependymomas and astrocytomas.
M P, Rubio, K M, Correa, V, Ramesh, M M, MacCollin, L B, Jacoby, A, von Deimling, J F, Gusella, D N, Louis   +7 more
openaire   +1 more source

Characterization of the neurofibromatosis type 2 gene

Otolaryngology–Head and Neck Surgery, 1999
D Bradley Welling, Robert L Daniels, Beth A Miles, Long‐sheng Chang   +3 more
openaire   +1 more source

Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2.

Cancer research, 2002
Mutations at splice sites or surrounding sequences have been reported to cause aberrant splicing. However, splicing errors can also occur without sequence alterations. We investigated three tumor suppressor genes for aberrant splicing in tumors.
Dieter, Kaufmann, Werner, Leistner, Petra, Kruse, Oliver, Kenner, Sven, Hoffmeyer, Christian, Hein, Walther, Vogel, Ludwine, Messiaen, Britta, Bartelt   +8 more
openaire   +1 more source

Integrative oncology: Addressing the global challenges of cancer prevention and treatment

Ca-A Cancer Journal for Clinicians, 2022
Jun J Mao,, Msce, Lorenzo Cohen, Karen M Mustian   +2 more
exaly  

Analysis of the neurofibromatosis type 2 gene in schwannomas

Cancer Genetics and Cytogenetics, 1994
Emilia K. Bijlsma, Philippe Merel, Andries Westerveld, Olivier Delattre, Gilles Thomas, Theo J.M. Hulsebos   +5 more
openaire   +1 more source

Expression of neurofibromatosis 2 transcript and gene product during mouse fetal development.

Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1997
Neurofibromatosis 2 (NF2) is an autosomal dominant inherited disorder that predisposes to benign tumors of the nervous system as well as a variety of ocular abnormalities. In contrast to NF1, NF2 is associated with only minor developmental abnormalities.
D P, Huynh, T M, Tran, T, Nechiporuk, S M, Pulst   +3 more
openaire   +1 more source

Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22.

American journal of human genetics, 1990
Neurofibromatosis 2 or bilateral acoustic neurofibromatosis (NF2) is a severe autosomal dominant disorder characterized by the development of multiple tumors of the nervous system, including meningiomas, gliomas, neurofibromas, ependymomas, and particularly acoustic neuromas. Polymorphic DNA markers have revealed frequent loss of one copy of chromosome
G A, Rouleau, B R, Seizinger, W, Wertelecki, J L, Haines, D W, Superneau, R L, Martuza, J F, Gusella   +6 more
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Joyce M Slingerland   +1 more
exaly